Global Infectious Disease Rapid Diagnostic Testing Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Infectious Disease Rapid Diagnostic Testing market size was valued at US$ million in 2023. With growing demand in downstream market, the Infectious Disease Rapid Diagnostic Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Infectious Disease Rapid Diagnostic Testing market. Infectious Disease Rapid Diagnostic Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infectious Disease Rapid Diagnostic Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infectious Disease Rapid Diagnostic Testing market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Infectious Disease Rapid Diagnostic Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Infectious Disease Rapid Diagnostic Testing market. It may include historical data, market segmentation by Type (e.g., Assays, Platforms), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infectious Disease Rapid Diagnostic Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Infectious Disease Rapid Diagnostic Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Infectious Disease Rapid Diagnostic Testing industry. This include advancements in Infectious Disease Rapid Diagnostic Testing technology, Infectious Disease Rapid Diagnostic Testing new entrants, Infectious Disease Rapid Diagnostic Testing new investment, and other innovations that are shaping the future of Infectious Disease Rapid Diagnostic Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infectious Disease Rapid Diagnostic Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Infectious Disease Rapid Diagnostic Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infectious Disease Rapid Diagnostic Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infectious Disease Rapid Diagnostic Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infectious Disease Rapid Diagnostic Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infectious Disease Rapid Diagnostic Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infectious Disease Rapid Diagnostic Testing market.
Market Segmentation:
Infectious Disease Rapid Diagnostic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Infectious Disease Rapid Diagnostic Testing market size was valued at US$ million in 2023. With growing demand in downstream market, the Infectious Disease Rapid Diagnostic Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Infectious Disease Rapid Diagnostic Testing market. Infectious Disease Rapid Diagnostic Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infectious Disease Rapid Diagnostic Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infectious Disease Rapid Diagnostic Testing market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Infectious Disease Rapid Diagnostic Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Infectious Disease Rapid Diagnostic Testing market. It may include historical data, market segmentation by Type (e.g., Assays, Platforms), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infectious Disease Rapid Diagnostic Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Infectious Disease Rapid Diagnostic Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Infectious Disease Rapid Diagnostic Testing industry. This include advancements in Infectious Disease Rapid Diagnostic Testing technology, Infectious Disease Rapid Diagnostic Testing new entrants, Infectious Disease Rapid Diagnostic Testing new investment, and other innovations that are shaping the future of Infectious Disease Rapid Diagnostic Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infectious Disease Rapid Diagnostic Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Infectious Disease Rapid Diagnostic Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infectious Disease Rapid Diagnostic Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infectious Disease Rapid Diagnostic Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infectious Disease Rapid Diagnostic Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infectious Disease Rapid Diagnostic Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infectious Disease Rapid Diagnostic Testing market.
Market Segmentation:
Infectious Disease Rapid Diagnostic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Assays
- Platforms
- Respiratory Infection
- Gastro-Intestinal Infection
- Center Nervous System Infection
- Hospital Acquired Infection
- Sexually Transmitted Infections
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Roche Ltd
- Danaher Corporation
- Luminex Corporation
- BGI Group
- bioMerieux S.A.
- DiaSorin S.p.A
- Hologic, Inc.
- Mesa Biotech
- Quidel Corporation
- Thermo Fisher Scientific Inc.
- GenMark Diagnostics
- CTK Biotech
- Becton Dickinson
- Cellex Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Rapid Diagnostic Testing Market Size 2019-2030
2.1.2 Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Infectious Disease Rapid Diagnostic Testing Segment by Type
2.2.1 Assays
2.2.2 Platforms
2.3 Infectious Disease Rapid Diagnostic Testing Market Size by Type
2.3.1 Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
2.4 Infectious Disease Rapid Diagnostic Testing Segment by Application
2.4.1 Respiratory Infection
2.4.2 Gastro-Intestinal Infection
2.4.3 Center Nervous System Infection
2.4.4 Hospital Acquired Infection
2.4.5 Sexually Transmitted Infections
2.4.6 Others
2.5 Infectious Disease Rapid Diagnostic Testing Market Size by Application
2.5.1 Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
3 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET SIZE BY PLAYER
3.1 Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Players
3.1.1 Global Infectious Disease Rapid Diagnostic Testing Revenue by Players (2019-2024)
3.1.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Rapid Diagnostic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING BY REGIONS
4.1 Infectious Disease Rapid Diagnostic Testing Market Size by Regions (2019-2024)
4.2 Americas Infectious Disease Rapid Diagnostic Testing Market Size Growth (2019-2024)
4.3 APAC Infectious Disease Rapid Diagnostic Testing Market Size Growth (2019-2024)
4.4 Europe Infectious Disease Rapid Diagnostic Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024)
5.2 Americas Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024)
5.3 Americas Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Rapid Diagnostic Testing Market Size by Region (2019-2024)
6.2 APAC Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024)
6.3 APAC Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease Rapid Diagnostic Testing by Country (2019-2024)
7.2 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024)
7.3 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Rapid Diagnostic Testing by Region (2019-2024)
8.2 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET FORECAST
10.1 Global Infectious Disease Rapid Diagnostic Testing Forecast by Regions (2025-2030)
10.1.1 Global Infectious Disease Rapid Diagnostic Testing Forecast by Regions (2025-2030)
10.1.2 Americas Infectious Disease Rapid Diagnostic Testing Forecast
10.1.3 APAC Infectious Disease Rapid Diagnostic Testing Forecast
10.1.4 Europe Infectious Disease Rapid Diagnostic Testing Forecast
10.1.5 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Forecast
10.2 Americas Infectious Disease Rapid Diagnostic Testing Forecast by Country (2025-2030)
10.2.1 United States Infectious Disease Rapid Diagnostic Testing Market Forecast
10.2.2 Canada Infectious Disease Rapid Diagnostic Testing Market Forecast
10.2.3 Mexico Infectious Disease Rapid Diagnostic Testing Market Forecast
10.2.4 Brazil Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3 APAC Infectious Disease Rapid Diagnostic Testing Forecast by Region (2025-2030)
10.3.1 China Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.2 Japan Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.3 Korea Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.4 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.5 India Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.6 Australia Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4 Europe Infectious Disease Rapid Diagnostic Testing Forecast by Country (2025-2030)
10.4.1 Germany Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4.2 France Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4.3 UK Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4.4 Italy Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4.5 Russia Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Forecast by Region (2025-2030)
10.5.1 Egypt Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5.2 South Africa Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5.3 Israel Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5.4 Turkey Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5.5 GCC Countries Infectious Disease Rapid Diagnostic Testing Market Forecast
10.6 Global Infectious Disease Rapid Diagnostic Testing Forecast by Type (2025-2030)
10.7 Global Infectious Disease Rapid Diagnostic Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Offered
11.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Roche Ltd
11.2.1 Roche Ltd Company Information
11.2.2 Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Offered
11.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Ltd Main Business Overview
11.2.5 Roche Ltd Latest Developments
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Information
11.3.2 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
11.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Danaher Corporation Main Business Overview
11.3.5 Danaher Corporation Latest Developments
11.4 Luminex Corporation
11.4.1 Luminex Corporation Company Information
11.4.2 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
11.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Luminex Corporation Main Business Overview
11.4.5 Luminex Corporation Latest Developments
11.5 BGI Group
11.5.1 BGI Group Company Information
11.5.2 BGI Group Infectious Disease Rapid Diagnostic Testing Product Offered
11.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BGI Group Main Business Overview
11.5.5 BGI Group Latest Developments
11.6 bioMerieux S.A.
11.6.1 bioMerieux S.A. Company Information
11.6.2 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Offered
11.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 bioMerieux S.A. Main Business Overview
11.6.5 bioMerieux S.A. Latest Developments
11.7 DiaSorin S.p.A
11.7.1 DiaSorin S.p.A Company Information
11.7.2 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Offered
11.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 DiaSorin S.p.A Main Business Overview
11.7.5 DiaSorin S.p.A Latest Developments
11.8 Hologic, Inc.
11.8.1 Hologic, Inc. Company Information
11.8.2 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
11.8.3 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Hologic, Inc. Main Business Overview
11.8.5 Hologic, Inc. Latest Developments
11.9 Mesa Biotech
11.9.1 Mesa Biotech Company Information
11.9.2 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Offered
11.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mesa Biotech Main Business Overview
11.9.5 Mesa Biotech Latest Developments
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Information
11.10.2 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
11.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quidel Corporation Main Business Overview
11.10.5 Quidel Corporation Latest Developments
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Information
11.11.2 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
11.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Thermo Fisher Scientific Inc. Main Business Overview
11.11.5 Thermo Fisher Scientific Inc. Latest Developments
11.12 GenMark Diagnostics
11.12.1 GenMark Diagnostics Company Information
11.12.2 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Offered
11.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 GenMark Diagnostics Main Business Overview
11.12.5 GenMark Diagnostics Latest Developments
11.13 CTK Biotech
11.13.1 CTK Biotech Company Information
11.13.2 CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Offered
11.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 CTK Biotech Main Business Overview
11.13.5 CTK Biotech Latest Developments
11.14 Becton Dickinson
11.14.1 Becton Dickinson Company Information
11.14.2 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Offered
11.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Becton Dickinson Main Business Overview
11.14.5 Becton Dickinson Latest Developments
11.15 Cellex Inc.
11.15.1 Cellex Inc. Company Information
11.15.2 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
11.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Cellex Inc. Main Business Overview
11.15.5 Cellex Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Disease Rapid Diagnostic Testing Market Size 2019-2030
2.1.2 Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Infectious Disease Rapid Diagnostic Testing Segment by Type
2.2.1 Assays
2.2.2 Platforms
2.3 Infectious Disease Rapid Diagnostic Testing Market Size by Type
2.3.1 Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
2.4 Infectious Disease Rapid Diagnostic Testing Segment by Application
2.4.1 Respiratory Infection
2.4.2 Gastro-Intestinal Infection
2.4.3 Center Nervous System Infection
2.4.4 Hospital Acquired Infection
2.4.5 Sexually Transmitted Infections
2.4.6 Others
2.5 Infectious Disease Rapid Diagnostic Testing Market Size by Application
2.5.1 Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
3 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET SIZE BY PLAYER
3.1 Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Players
3.1.1 Global Infectious Disease Rapid Diagnostic Testing Revenue by Players (2019-2024)
3.1.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Rapid Diagnostic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING BY REGIONS
4.1 Infectious Disease Rapid Diagnostic Testing Market Size by Regions (2019-2024)
4.2 Americas Infectious Disease Rapid Diagnostic Testing Market Size Growth (2019-2024)
4.3 APAC Infectious Disease Rapid Diagnostic Testing Market Size Growth (2019-2024)
4.4 Europe Infectious Disease Rapid Diagnostic Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024)
5.2 Americas Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024)
5.3 Americas Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Rapid Diagnostic Testing Market Size by Region (2019-2024)
6.2 APAC Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024)
6.3 APAC Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Disease Rapid Diagnostic Testing by Country (2019-2024)
7.2 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024)
7.3 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Disease Rapid Diagnostic Testing by Region (2019-2024)
8.2 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET FORECAST
10.1 Global Infectious Disease Rapid Diagnostic Testing Forecast by Regions (2025-2030)
10.1.1 Global Infectious Disease Rapid Diagnostic Testing Forecast by Regions (2025-2030)
10.1.2 Americas Infectious Disease Rapid Diagnostic Testing Forecast
10.1.3 APAC Infectious Disease Rapid Diagnostic Testing Forecast
10.1.4 Europe Infectious Disease Rapid Diagnostic Testing Forecast
10.1.5 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Forecast
10.2 Americas Infectious Disease Rapid Diagnostic Testing Forecast by Country (2025-2030)
10.2.1 United States Infectious Disease Rapid Diagnostic Testing Market Forecast
10.2.2 Canada Infectious Disease Rapid Diagnostic Testing Market Forecast
10.2.3 Mexico Infectious Disease Rapid Diagnostic Testing Market Forecast
10.2.4 Brazil Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3 APAC Infectious Disease Rapid Diagnostic Testing Forecast by Region (2025-2030)
10.3.1 China Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.2 Japan Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.3 Korea Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.4 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.5 India Infectious Disease Rapid Diagnostic Testing Market Forecast
10.3.6 Australia Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4 Europe Infectious Disease Rapid Diagnostic Testing Forecast by Country (2025-2030)
10.4.1 Germany Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4.2 France Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4.3 UK Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4.4 Italy Infectious Disease Rapid Diagnostic Testing Market Forecast
10.4.5 Russia Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Forecast by Region (2025-2030)
10.5.1 Egypt Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5.2 South Africa Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5.3 Israel Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5.4 Turkey Infectious Disease Rapid Diagnostic Testing Market Forecast
10.5.5 GCC Countries Infectious Disease Rapid Diagnostic Testing Market Forecast
10.6 Global Infectious Disease Rapid Diagnostic Testing Forecast by Type (2025-2030)
10.7 Global Infectious Disease Rapid Diagnostic Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Offered
11.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Roche Ltd
11.2.1 Roche Ltd Company Information
11.2.2 Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Offered
11.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Ltd Main Business Overview
11.2.5 Roche Ltd Latest Developments
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Information
11.3.2 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
11.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Danaher Corporation Main Business Overview
11.3.5 Danaher Corporation Latest Developments
11.4 Luminex Corporation
11.4.1 Luminex Corporation Company Information
11.4.2 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
11.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Luminex Corporation Main Business Overview
11.4.5 Luminex Corporation Latest Developments
11.5 BGI Group
11.5.1 BGI Group Company Information
11.5.2 BGI Group Infectious Disease Rapid Diagnostic Testing Product Offered
11.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BGI Group Main Business Overview
11.5.5 BGI Group Latest Developments
11.6 bioMerieux S.A.
11.6.1 bioMerieux S.A. Company Information
11.6.2 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Offered
11.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 bioMerieux S.A. Main Business Overview
11.6.5 bioMerieux S.A. Latest Developments
11.7 DiaSorin S.p.A
11.7.1 DiaSorin S.p.A Company Information
11.7.2 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Offered
11.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 DiaSorin S.p.A Main Business Overview
11.7.5 DiaSorin S.p.A Latest Developments
11.8 Hologic, Inc.
11.8.1 Hologic, Inc. Company Information
11.8.2 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
11.8.3 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Hologic, Inc. Main Business Overview
11.8.5 Hologic, Inc. Latest Developments
11.9 Mesa Biotech
11.9.1 Mesa Biotech Company Information
11.9.2 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Offered
11.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mesa Biotech Main Business Overview
11.9.5 Mesa Biotech Latest Developments
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Information
11.10.2 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
11.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quidel Corporation Main Business Overview
11.10.5 Quidel Corporation Latest Developments
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Information
11.11.2 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
11.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Thermo Fisher Scientific Inc. Main Business Overview
11.11.5 Thermo Fisher Scientific Inc. Latest Developments
11.12 GenMark Diagnostics
11.12.1 GenMark Diagnostics Company Information
11.12.2 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Offered
11.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 GenMark Diagnostics Main Business Overview
11.12.5 GenMark Diagnostics Latest Developments
11.13 CTK Biotech
11.13.1 CTK Biotech Company Information
11.13.2 CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Offered
11.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 CTK Biotech Main Business Overview
11.13.5 CTK Biotech Latest Developments
11.14 Becton Dickinson
11.14.1 Becton Dickinson Company Information
11.14.2 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Offered
11.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Becton Dickinson Main Business Overview
11.14.5 Becton Dickinson Latest Developments
11.15 Cellex Inc.
11.15.1 Cellex Inc. Company Information
11.15.2 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
11.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Cellex Inc. Main Business Overview
11.15.5 Cellex Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Assays
Table 3. Major Players of Platforms
Table 4. Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 7. Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 10. Global Infectious Disease Rapid Diagnostic Testing Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Player (2019-2024)
Table 12. Infectious Disease Rapid Diagnostic Testing Key Players Head office and Products Offered
Table 13. Infectious Disease Rapid Diagnostic Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Infectious Disease Rapid Diagnostic Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Regions (2019-2024)
Table 18. Global Infectious Disease Rapid Diagnostic Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country (2019-2024)
Table 22. Americas Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 24. Americas Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 26. APAC Infectious Disease Rapid Diagnostic Testing Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2019-2024)
Table 28. APAC Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 30. APAC Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 32. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country (2019-2024)
Table 34. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 36. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Infectious Disease Rapid Diagnostic Testing
Table 45. Key Market Challenges & Risks of Infectious Disease Rapid Diagnostic Testing
Table 46. Key Industry Trends of Infectious Disease Rapid Diagnostic Testing
Table 47. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Abbott Laboratories Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 52. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Offered
Table 53. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. Roche Ltd Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 57. Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Offered
Table 58. Roche Ltd Main Business
Table 59. Roche Ltd Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Roche Ltd Latest Developments
Table 61. Danaher Corporation Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 62. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
Table 63. Danaher Corporation Main Business
Table 64. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Danaher Corporation Latest Developments
Table 66. Luminex Corporation Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 67. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
Table 68. Luminex Corporation Main Business
Table 69. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Luminex Corporation Latest Developments
Table 71. BGI Group Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 72. BGI Group Infectious Disease Rapid Diagnostic Testing Product Offered
Table 73. BGI Group Main Business
Table 74. BGI Group Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. BGI Group Latest Developments
Table 76. bioMerieux S.A. Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 77. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Offered
Table 78. bioMerieux S.A. Main Business
Table 79. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. bioMerieux S.A. Latest Developments
Table 81. DiaSorin S.p.A Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 82. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Offered
Table 83. DiaSorin S.p.A Main Business
Table 84. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. DiaSorin S.p.A Latest Developments
Table 86. Hologic, Inc. Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 87. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
Table 88. Hologic, Inc. Main Business
Table 89. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Hologic, Inc. Latest Developments
Table 91. Mesa Biotech Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 92. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Offered
Table 93. Mesa Biotech Main Business
Table 94. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Mesa Biotech Latest Developments
Table 96. Quidel Corporation Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 97. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
Table 98. Quidel Corporation Main Business
Table 99. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Quidel Corporation Latest Developments
Table 101. Thermo Fisher Scientific Inc. Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 102. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
Table 103. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Thermo Fisher Scientific Inc. Main Business
Table 105. Thermo Fisher Scientific Inc. Latest Developments
Table 106. GenMark Diagnostics Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 107. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Offered
Table 108. GenMark Diagnostics Main Business
Table 109. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. GenMark Diagnostics Latest Developments
Table 111. CTK Biotech Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 112. CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Offered
Table 113. CTK Biotech Main Business
Table 114. CTK Biotech Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. CTK Biotech Latest Developments
Table 116. Becton Dickinson Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 117. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Offered
Table 118. Becton Dickinson Main Business
Table 119. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Becton Dickinson Latest Developments
Table 121. Cellex Inc. Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 122. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
Table 123. Cellex Inc. Main Business
Table 124. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Cellex Inc. Latest Developments
.
Table 1. Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Assays
Table 3. Major Players of Platforms
Table 4. Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 7. Infectious Disease Rapid Diagnostic Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 10. Global Infectious Disease Rapid Diagnostic Testing Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Player (2019-2024)
Table 12. Infectious Disease Rapid Diagnostic Testing Key Players Head office and Products Offered
Table 13. Infectious Disease Rapid Diagnostic Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Infectious Disease Rapid Diagnostic Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Regions (2019-2024)
Table 18. Global Infectious Disease Rapid Diagnostic Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country (2019-2024)
Table 22. Americas Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 24. Americas Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 26. APAC Infectious Disease Rapid Diagnostic Testing Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2019-2024)
Table 28. APAC Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 30. APAC Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 32. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country (2019-2024)
Table 34. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 36. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Infectious Disease Rapid Diagnostic Testing
Table 45. Key Market Challenges & Risks of Infectious Disease Rapid Diagnostic Testing
Table 46. Key Industry Trends of Infectious Disease Rapid Diagnostic Testing
Table 47. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Abbott Laboratories Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 52. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Offered
Table 53. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. Roche Ltd Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 57. Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Offered
Table 58. Roche Ltd Main Business
Table 59. Roche Ltd Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Roche Ltd Latest Developments
Table 61. Danaher Corporation Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 62. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
Table 63. Danaher Corporation Main Business
Table 64. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Danaher Corporation Latest Developments
Table 66. Luminex Corporation Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 67. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
Table 68. Luminex Corporation Main Business
Table 69. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Luminex Corporation Latest Developments
Table 71. BGI Group Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 72. BGI Group Infectious Disease Rapid Diagnostic Testing Product Offered
Table 73. BGI Group Main Business
Table 74. BGI Group Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. BGI Group Latest Developments
Table 76. bioMerieux S.A. Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 77. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Offered
Table 78. bioMerieux S.A. Main Business
Table 79. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. bioMerieux S.A. Latest Developments
Table 81. DiaSorin S.p.A Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 82. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Offered
Table 83. DiaSorin S.p.A Main Business
Table 84. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. DiaSorin S.p.A Latest Developments
Table 86. Hologic, Inc. Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 87. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
Table 88. Hologic, Inc. Main Business
Table 89. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Hologic, Inc. Latest Developments
Table 91. Mesa Biotech Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 92. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Offered
Table 93. Mesa Biotech Main Business
Table 94. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Mesa Biotech Latest Developments
Table 96. Quidel Corporation Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 97. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Offered
Table 98. Quidel Corporation Main Business
Table 99. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Quidel Corporation Latest Developments
Table 101. Thermo Fisher Scientific Inc. Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 102. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
Table 103. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Thermo Fisher Scientific Inc. Main Business
Table 105. Thermo Fisher Scientific Inc. Latest Developments
Table 106. GenMark Diagnostics Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 107. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Offered
Table 108. GenMark Diagnostics Main Business
Table 109. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. GenMark Diagnostics Latest Developments
Table 111. CTK Biotech Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 112. CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Offered
Table 113. CTK Biotech Main Business
Table 114. CTK Biotech Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. CTK Biotech Latest Developments
Table 116. Becton Dickinson Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 117. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Offered
Table 118. Becton Dickinson Main Business
Table 119. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. Becton Dickinson Latest Developments
Table 121. Cellex Inc. Details, Company Type, Infectious Disease Rapid Diagnostic Testing Area Served and Its Competitors
Table 122. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Offered
Table 123. Cellex Inc. Main Business
Table 124. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Cellex Inc. Latest Developments
LIST OF FIGURES
.
Figure 1. Infectious Disease Rapid Diagnostic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Infectious Disease Rapid Diagnostic Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country/Region (2023)
Figure 8. Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type in 2023
Figure 10. Infectious Disease Rapid Diagnostic Testing in Respiratory Infection
Figure 11. Global Infectious Disease Rapid Diagnostic Testing Market: Respiratory Infection (2019-2024) & ($ Millions)
Figure 12. Infectious Disease Rapid Diagnostic Testing in Gastro-Intestinal Infection
Figure 13. Global Infectious Disease Rapid Diagnostic Testing Market: Gastro-Intestinal Infection (2019-2024) & ($ Millions)
Figure 14. Infectious Disease Rapid Diagnostic Testing in Center Nervous System Infection
Figure 15. Global Infectious Disease Rapid Diagnostic Testing Market: Center Nervous System Infection (2019-2024) & ($ Millions)
Figure 16. Infectious Disease Rapid Diagnostic Testing in Hospital Acquired Infection
Figure 17. Global Infectious Disease Rapid Diagnostic Testing Market: Hospital Acquired Infection (2019-2024) & ($ Millions)
Figure 18. Infectious Disease Rapid Diagnostic Testing in Sexually Transmitted Infections
Figure 19. Global Infectious Disease Rapid Diagnostic Testing Market: Sexually Transmitted Infections (2019-2024) & ($ Millions)
Figure 20. Infectious Disease Rapid Diagnostic Testing in Others
Figure 21. Global Infectious Disease Rapid Diagnostic Testing Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application in 2023
Figure 23. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Player in 2023
Figure 24. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Infectious Disease Rapid Diagnostic Testing Market Size 2019-2024 ($ Millions)
Figure 26. APAC Infectious Disease Rapid Diagnostic Testing Market Size 2019-2024 ($ Millions)
Figure 27. Europe Infectious Disease Rapid Diagnostic Testing Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size 2019-2024 ($ Millions)
Figure 29. Americas Infectious Disease Rapid Diagnostic Testing Value Market Share by Country in 2023
Figure 30. United States Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region in 2023
Figure 35. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type in 2023
Figure 36. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application in 2023
Figure 37. China Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country in 2023
Figure 44. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Figure 45. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Figure 46. Germany Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 60. APAC Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 61. Europe Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 63. United States Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 64. Canada Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 67. China Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 68. Japan Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 69. Korea Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 71. India Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 72. Australia Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 73. Germany Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 74. France Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 75. UK Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 76. Italy Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 77. Russia Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 78. Spain Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 81. Israel Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 84. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share Forecast by Application (2025-2030)
.
Figure 1. Infectious Disease Rapid Diagnostic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Infectious Disease Rapid Diagnostic Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country/Region (2023)
Figure 8. Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type in 2023
Figure 10. Infectious Disease Rapid Diagnostic Testing in Respiratory Infection
Figure 11. Global Infectious Disease Rapid Diagnostic Testing Market: Respiratory Infection (2019-2024) & ($ Millions)
Figure 12. Infectious Disease Rapid Diagnostic Testing in Gastro-Intestinal Infection
Figure 13. Global Infectious Disease Rapid Diagnostic Testing Market: Gastro-Intestinal Infection (2019-2024) & ($ Millions)
Figure 14. Infectious Disease Rapid Diagnostic Testing in Center Nervous System Infection
Figure 15. Global Infectious Disease Rapid Diagnostic Testing Market: Center Nervous System Infection (2019-2024) & ($ Millions)
Figure 16. Infectious Disease Rapid Diagnostic Testing in Hospital Acquired Infection
Figure 17. Global Infectious Disease Rapid Diagnostic Testing Market: Hospital Acquired Infection (2019-2024) & ($ Millions)
Figure 18. Infectious Disease Rapid Diagnostic Testing in Sexually Transmitted Infections
Figure 19. Global Infectious Disease Rapid Diagnostic Testing Market: Sexually Transmitted Infections (2019-2024) & ($ Millions)
Figure 20. Infectious Disease Rapid Diagnostic Testing in Others
Figure 21. Global Infectious Disease Rapid Diagnostic Testing Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application in 2023
Figure 23. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Player in 2023
Figure 24. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Infectious Disease Rapid Diagnostic Testing Market Size 2019-2024 ($ Millions)
Figure 26. APAC Infectious Disease Rapid Diagnostic Testing Market Size 2019-2024 ($ Millions)
Figure 27. Europe Infectious Disease Rapid Diagnostic Testing Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size 2019-2024 ($ Millions)
Figure 29. Americas Infectious Disease Rapid Diagnostic Testing Value Market Share by Country in 2023
Figure 30. United States Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region in 2023
Figure 35. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type in 2023
Figure 36. APAC Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application in 2023
Figure 37. China Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country in 2023
Figure 44. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Figure 45. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Figure 46. Germany Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Infectious Disease Rapid Diagnostic Testing Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 60. APAC Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 61. Europe Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 63. United States Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 64. Canada Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 67. China Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 68. Japan Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 69. Korea Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 71. India Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 72. Australia Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 73. Germany Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 74. France Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 75. UK Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 76. Italy Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 77. Russia Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 78. Spain Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 81. Israel Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Infectious Disease Rapid Diagnostic Testing Market Size 2025-2030 ($ Millions)
Figure 84. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Artificial Urinary Sphincter Market Growth 2024-2030
US$ 3,660.00
December 2024
91 pages
Global Blood Purification Equipment Market Growth 2025-2031
US$ 3,660.00
March 2025
112 pages
Global Soft Tissue Suture Anchors Market Growth 2024-2030
US$ 3,660.00
October 2024
132 pages
Global Retrieval Bag Market Growth 2023-2029
US$ 3,660.00
March 2023
104 pages
